Management of salivary gland malignant tumor: The policlinico Umberto I, sapienza university of rome head and neck unit clinical recommendations

Salivary gland malignant tumor (SGMT) is uncommon, accounting less than 5% of all head and neck cancers, and comprises numerous histological entities (Mifsud et al., 2016). The clinicopathologic spectrum ranges from low-grade histologies to high-grade tumors, with important prognosis differences (Terhaard et al., 2004). Nowadays SGMT still represents an assortment of disease states and continues to pose management challenges. Guidelines for SGMT suggest a variety of strategies, reflecting the lack of high-quality evidence demonstrating the superiority of any one approach (National Comprehensive Cancer Network, 2017).

Source: Critical Reviews in Oncology Hematology - October 27, 2017 Category: Cancer & Oncology Authors: Francesca De Felice, Marco de incentiis, Valentino Valentini, Daniela Musio, Silvia Mezi, Luigi Lo Mele, Marco Della Monaca, Vittorio D ’Aguanno, Valentina Terenzi, Martina Di Brino, Edoardo Brauner, Nadia Bulzonetti, Gianluca Tenore, Giulia Pomati, And Source Type: research